4.2 Review

Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials

期刊

CURRENT RHEUMATOLOGY REPORTS
卷 23, 期 2, 页码 -

出版社

SPRINGER
DOI: 10.1007/s11926-020-00975-8

关键词

Turmeric; Curcumin; Osteoarthritis; Meta-analysis; RCT

向作者/读者索取更多资源

Turmeric extract is a safe and effective option for managing knee osteoarthritis symptoms, with significant improvement in pain and physical function compared to placebo, similar efficacy to NSAIDs, and fewer adverse events. However, current evidence from short-term studies is heterogeneous, with moderate risk of bias, leading to some uncertainty about the true effect.
Purpose of the ReviewFinding appropriate pharmacological options to treat osteoarthritis (OA) remain challenging. We aimed to determine the efficacy and safety of all types of turmeric extracts for the management of knee OA.Recent FindingsSixteen RCTs of up to 16 weeks duration including 1810 adults with knee OA were included. Eleven RCTs compared the efficacy of turmeric extracts with placebo and five with active comparators (NSAIDs). The overall risk bias of included RCTs was moderate. Turmeric extracts significantly reduced knee pain (SMD -0.82, 95% CI -1.17 to -0.47, I-2 =86.23%) and improved physical function (SMD -0.75, 95% CI -1.18 to -0.33, I-2 =90.05%) compared to placebo but had similar effects compared to NSAIDs. BMI was the major contributor to heterogeneity in the placebo-controlled studies (explained 37.68% and 67.24%, respectively, in the models) and modified the effects of the turmeric on pain and physical function with less improvement with higher BMI (SMD 0.26 95% CI 0.04 to 0.48; SMD 0.48 95% CI 0.21 to 0.74). No significant between-group differences were reported for either biochemical markers or imaging outcomes. Turmeric extracts had 12% fewer adverse events than NSAIDs and similar rates to placebo.SummaryTurmeric extract is a safe and effective option for the symptomatic management of knee OA, compared to placebo or NSAIDs. However, current evidence from short-term studies is heterogeneous and has moderate risk of bias leading to some uncertainty about the true effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据